Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66580-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- NSUN2 antibody
- Antibody type
- Monoclonal
- Description
- NSUN2 antibody (Cat. #66580-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2H5A2
- Vial size
- 20ul, 150ul
Submitted references NCAPG confers ferroptosis resistance of hepatocellular carcinoma through NSUN2-mediated m5C modification.
Enhanced 5-methylcytosine methylation of PSD4 facilitates vasculogenic mimicry in breast cancer brain metastases through ferroptotic resistance.
The m((5))C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism.
Hypoxia-induced NSUN2 promotes the progression of colon cancer by modulating the discrepant cleavage of tRNA-Arg.
NSUN2 mediates distinct pathways to regulate enterovirus 71 replication.
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.
N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis.
Huang Z, Wang J, He A, Feng Q, Yang J, Wu L, Liao W
Cellular signalling 2026 Feb;138:112256
Cellular signalling 2026 Feb;138:112256
Enhanced 5-methylcytosine methylation of PSD4 facilitates vasculogenic mimicry in breast cancer brain metastases through ferroptotic resistance.
Li M, Cui C, Li J, Zhou J, Chen S, Yan J, Zhang D, Zhang Y, Xie P, Yao Y, Ni F, An M, Zhang W, Fu B
Cellular signalling 2025 Nov;135:112022
Cellular signalling 2025 Nov;135:112022
The m((5))C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism.
Li S, Liu Y, Wu X, Pan M, Zhao H, Hong Y, Zhang Q, Hu S, Ouyang A, Li G, Wu M, Fan S, Jia Z, Zhao S, Wu G, Gao X, Yang Z, Chen Z
Cell reports 2025 May 27;44(5):115661
Cell reports 2025 May 27;44(5):115661
Hypoxia-induced NSUN2 promotes the progression of colon cancer by modulating the discrepant cleavage of tRNA-Arg.
Luan N, Cao Y, Sun J, Ye X, Zhou Q, Tang Z, Wang J
International immunopharmacology 2025 Aug 28;161:115023
International immunopharmacology 2025 Aug 28;161:115023
NSUN2 mediates distinct pathways to regulate enterovirus 71 replication.
Liu L, Chen Z, Zhang K, Hao H, Ma L, Liu H, Yu B, Ding S, Zhang X, Zhu M, Guo X, Liu Y, Liu H, Huang F, Peng K, Guan W
Virologica Sinica 2024 Aug;39(4):574-586
Virologica Sinica 2024 Aug;39(4):574-586
NSUN2 is a glucose sensor suppressing cGAS/STING to maintain tumorigenesis and immunotherapy resistance.
Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, Pan BS, Cai Z, Tsai PJ, Tsai YS, Chen ZZ, Li HY, Lin HK
Cell metabolism 2023 Oct 3;35(10):1782-1798.e8
Cell metabolism 2023 Oct 3;35(10):1782-1798.e8
RNA methyltransferase NSun2 deficiency promotes neurodegeneration through epitranscriptomic regulation of tau phosphorylation.
Kim YA, Siddiqui T, Blaze J, Cosacak MI, Winters T, Kumar A, Tein E, Sproul AA, Teich AF, Bartolini F, Akbarian S, Kizil C, Hargus G, Santa-Maria I
Acta neuropathologica 2023 Jan;145(1):29-48
Acta neuropathologica 2023 Jan;145(1):29-48
N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis.
Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, Wang F, Ma NF, Guan X, Yun JP, Wang FW, Xu RH, Dan Xie
Nature communications 2019 Oct 16;10(1):4695
Nature communications 2019 Oct 16;10(1):4695
No comments: Submit comment
No validations: Submit validation data